BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Clinical Outcome
5 results:

  • 1. lncRNA TRHDE-AS1 Correlated with Genomic Landscape and clinical outcome in Glioma.
    Xie J; Lin Y; Li Y; Fang A; Li X; Wang S; Li W
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239411
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
    Labussière M; Di Stefano AL; Gleize V; Boisselier B; Giry M; Mangesius S; Bruno A; Paterra R; Marie Y; Rahimian A; Finocchiaro G; Houlston RS; Hoang-Xuan K; Idbaih A; Delattre JY; Mokhtari K; Sanson M
    Br J Cancer; 2014 Nov; 111(10):2024-32. PubMed ID: 25314060
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Round cell tumors of bone: an update on recent molecular genetic advances.
    Wei S; Siegal GP
    Adv Anat Pathol; 2014 Sep; 21(5):359-72. PubMed ID: 25105937
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.
    Suzuki A; Nobusawa S; Natsume A; Suzuki H; Kim YH; Yokoo H; Nagaishi M; Ikota H; Nakazawa T; Wakabayashi T; Ohgaki H; Nakazato Y
    J Neurooncol; 2014 Nov; 120(2):283-91. PubMed ID: 25085214
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Frequent ATRX, cic, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
    Jiao Y; Killela PJ; Reitman ZJ; Rasheed AB; Heaphy CM; de Wilde RF; Rodriguez FJ; Rosemberg S; Oba-Shinjo SM; Nagahashi Marie SK; Bettegowda C; Agrawal N; Lipp E; Pirozzi C; Lopez G; He Y; Friedman H; Friedman AH; Riggins GJ; Holdhoff M; Burger P; McLendon R; Bigner DD; Vogelstein B; Meeker AK; Kinzler KW; Papadopoulos N; Diaz LA; Yan H
    Oncotarget; 2012 Jul; 3(7):709-22. PubMed ID: 22869205
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.